Literature DB >> 25722198

Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season.

Fiona Havers1, Brendan Flannery1, Jessie R Clippard1, Manjusha Gaglani2, Richard K Zimmerman3, Lisa A Jackson4, Joshua G Petrie5, Huong Q McLean6, Mary Patricia Nowalk3, Michael L Jackson4, Arnold S Monto5, Edward A Belongia6, Heather F Eng7, Lois Lamerato8, Angela P Campbell1, Alicia M Fry1.   

Abstract

During the 2013-2014 influenza season, we analyzed data from 6004 outpatients aged ≥6 months with acute respiratory illness (ARI). Among the 2786 ARI patients at higher risk for influenza complications, 835 (30%) presented to care ≤2 days from symptom onset; among those, 126 (15%) were prescribed an antiviral medication. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  ambulatory care; antiviral treatment; influenza; neuraminidase inhibitors

Mesh：

Substances：

Year:  2015        PMID： 25722198      PMCID： PMC4542604          DOI： 10.1093/cid/civ146

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Adult hospitalizations for laboratory-positive influenza during the 2005-2006 through 2007-2008 seasons in the United States.

Authors:  Christine N Dao; Laurie Kamimoto; Mackenzie Nowell; Arthur Reingold; Ken Gershman; James Meek; Kathryn E Arnold; Monica Farley; Patricia Ryan; Ruth Lynfield; Craig Morin; Joan Baumbach; Emily Hancock; Shelley Zansky; Nancy M Bennett; Ann Thomas; Meredith Vandermeer; David L Kirschke; William Schaffner; Lyn Finelli
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

2.  Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participants.

Authors:  Marc Lipsitch; Miguel A Hernán
Journal:  Clin Infect Dis       Date:  2013-07-24       Impact factor: 9.079

3.  Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials.

Authors:  Miguel A Hernán; Marc Lipsitch
Journal:  Clin Infect Dis       Date:  2011-06-15       Impact factor: 9.079

4.  Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Anthony E Fiore; Alicia Fry; David Shay; Larisa Gubareva; Joseph S Bresee; Timothy M Uyeki
Journal:  MMWR Recomm Rep       Date:  2011-01-21

Review 5.  Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.

Authors:  Joanna Dobson; Richard J Whitley; Stuart Pocock; Arnold S Monto
Journal:  Lancet       Date:  2015-01-30       Impact factor: 79.321

6.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

7.  Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.

Authors:  Fiona Havers; Swathi Thaker; Jessie R Clippard; Michael Jackson; Huong Q McLean; Manjusha Gaglani; Arnold S Monto; Richard K Zimmerman; Lisa Jackson; Josh G Petrie; Mary Patricia Nowalk; Krissy K Moehling; Brendan Flannery; Mark G Thompson; Alicia M Fry
Journal:  Clin Infect Dis       Date:  2014-07-16       Impact factor: 9.079

8.  Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.

Authors:  Alicia M Fry; Doli Goswami; Kamrun Nahar; Amina Tahia Sharmin; Mustafizur Rahman; Larisa Gubareva; Tasnim Azim; Joseph Bresee; Stephen P Luby; W Abdullah Brooks
Journal:  Lancet Infect Dis       Date:  2013-11-22       Impact factor: 25.071

9.  Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015.

Authors:  Brendan Flannery; Jessie Clippard; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Joshua G Petrie; Huong Q McLean; Edward A Belongia; Manjusha Gaglani; LaShondra Berman; Angie Foust; Wendy Sessions; Swathi N Thaker; Sarah Spencer; Alicia M Fry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-01-16       Impact factor: 17.586

Review 10.  Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.

Authors:  Stella G Muthuri; Sudhir Venkatesan; Puja R Myles; Jo Leonardi-Bee; Tarig S A Al Khuwaitir; Adbullah Al Mamun; Ashish P Anovadiya; Eduardo Azziz-Baumgartner; Clarisa Báez; Matteo Bassetti; Bojana Beovic; Barbara Bertisch; Isabelle Bonmarin; Robert Booy; Victor H Borja-Aburto; Heinz Burgmann; Bin Cao; Jordi Carratala; Justin T Denholm; Samuel R Dominguez; Pericles A D Duarte; Gal Dubnov-Raz; Marcela Echavarria; Sergio Fanella; Zhancheng Gao; Patrick Gérardin; Maddalena Giannella; Sophie Gubbels; Jethro Herberg; Anjarath L Higuera Iglesias; Peter H Hoger; Xiaoyun Hu; Quazi T Islam; Mirela F Jiménez; Amr Kandeel; Gerben Keijzers; Hossein Khalili; Marian Knight; Koichiro Kudo; Gabriela Kusznierz; Ilija Kuzman; Arthur M C Kwan; Idriss Lahlou Amine; Eduard Langenegger; Kamran B Lankarani; Yee-Sin Leo; Rita Linko; Pei Liu; Faris Madanat; Elga Mayo-Montero; Allison McGeer; Ziad Memish; Gokhan Metan; Auksė Mickiene; Dragan Mikić; Kristin G I Mohn; Ahmadreza Moradi; Pagbajabyn Nymadawa; Maria E Oliva; Mehpare Ozkan; Dhruv Parekh; Mical Paul; Fernando P Polack; Barbara A Rath; Alejandro H Rodríguez; Elena B Sarrouf; Anna C Seale; Bunyamin Sertogullarindan; Marilda M Siqueira; Joanna Skręt-Magierło; Frank Stephan; Ewa Talarek; Julian W Tang; Kelvin K W To; Antoni Torres; Selda H Törün; Dat Tran; Timothy M Uyeki; Annelies Van Zwol; Wendy Vaudry; Tjasa Vidmar; Renata T C Yokota; Paul Zarogoulidis; Jonathan S Nguyen-Van-Tam
Journal:  Lancet Respir Med       Date:  2014-03-19       Impact factor: 30.700
View more
  7 in total

1.  Oseltamivir Treatment of Influenza in Children.

Authors:  Timothy M Uyeki
Journal:  Clin Infect Dis       Date:  2018-05-02       Impact factor: 9.079

2.  Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia.

Authors:  Ikwo K Oboho; Anna Bramley; Lyn Finelli; Alicia Fry; Krow Ampofo; Sandra R Arnold; Wesley H Self; Derek J Williams; D Mark Courtney; Yuwei Zhu; Evan J Anderson; Carlos G Grijalva; Jonathan A McCullers; Richard G Wunderink; Andrew T Pavia; Kathryn M Edwards; Seema Jain
Journal:  Open Forum Infect Dis       Date:  2016-12-27       Impact factor: 3.835

3.  Model-Informed Repurposing of Medicines for SARS-CoV-2: Extrapolation of Antiviral Activity and Dose Rationale for Paediatric Patients.

Authors:  Federico Romano; Salvatore D'Agate; Oscar Della Della Pasqua
Journal:  Pharmaceutics       Date:  2021-08-19       Impact factor: 6.321

4.  Influenza Antiviral Prescribing Practices and the Influence of Rapid Testing Among Primary Care Providers in the US, 2009-2016.

Authors:  Ashley L Fowlkes; Andrea Steffens; Carrie Reed; Jonathan L Temte; Angela P Campbell
Journal:  Open Forum Infect Dis       Date:  2019-04-26       Impact factor: 3.835

5.  Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons-United States, 2011-2016.

Authors:  Rebekah J Stewart; Brendan Flannery; Jessie R Chung; Manjusha Gaglani; Michael Reis; Richard K Zimmerman; Mary Patricia Nowalk; Lisa Jackson; Michael L Jackson; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Alicia M Fry; Fiona P Havers
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 20.999

6.  Intravenous peramivir vs oral oseltamivir in high-risk emergency department patients with influenza: Results from a pilot randomized controlled study.

Authors:  Yu-Hsiang Hsieh; Andrea F Dugas; Frank LoVecchio; Breana McBryde; Erin P Ricketts; Kathryn Saliba-Shaw; Richard E Rothman
Journal:  Influenza Other Respir Viruses       Date:  2020-10-02       Impact factor: 4.380

7.  Classification and Regression Tree (CART) analysis to predict influenza in primary care patients.

Authors:  Richard K Zimmerman; G K Balasubramani; Mary Patricia Nowalk; Heather Eng; Leonard Urbanski; Michael L Jackson; Lisa A Jackson; Huong Q McLean; Edward A Belongia; Arnold S Monto; Ryan E Malosh; Manjusha Gaglani; Lydia Clipper; Brendan Flannery; Stephen R Wisniewski
Journal:  BMC Infect Dis       Date:  2016-09-22       Impact factor: 3.667
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.